XTL Biopharmaceuticals Ltd. ( XTLB) - Stock Earnings
XTLB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -1.6 million USD | 0 USD |
| 2023Q2 | -364000 USD | — USD |
| 2023Q3 | -215000 USD | — USD |
XTLB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | 1.9 million USD | 1.5 million USD |
| 2022 | -2.3 million USD | -459000 USD |
| 2023 | -2.2 million USD | — USD |
XTLB
Price: $2.92
52 week price:
Earnings Per Share: -0.90 USD
P/E Ratio: -0.90
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 5727
Ebitda: -1.4 millionMarket Capitalization: 6.4 million